astrazeneca glp-1 AstraZeneca's Bydureon gets a facelift, but can it stand out in a market that's only getting tougher? AstraZeneca targets obesity market with

The most common side effects are mild and transient: water retention, tingling or numbness (most often in the hands), and occasional fatigue or headache shortly after injection

Missing doses allows blood glucose levels to rise, potentially leading to hyperglycemic symptoms including increased thirst, frequent urination, fatigue, and blurred vision

Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice

The biggest difference comes down to dose, pacing, and how much support youre looking for

BPC-157: The Healing Peptide Everyone's Talking About (What We Actually Know) BPC-157 is one of the most-discussed peptides on social media, with claims of accelerated tendon healing, gut repair, and neuroprotection -- but the honest reality is that the evidence comes almost entirely from animal studies, with essentially no completed human clinical trials to back the widespread claims